## 

## 

||Trustee name||Office (ifany)|Dates acted ifnot for whole<br>year|Name ofpemon (or body)<br>entitled ioappoint<br>trustee<br>ifan|Name ofpemon (or body)<br>entitled ioappoint<br>trustee<br>ifan|Name ofpemon (or body)<br>entitled ioappoint<br>trustee<br>ifan|
|---|---|---|---|---|---|---|---|
||Terence McCormack||President|14.09.2021 —31.12.2022||||
||Ian Wilkinson||Vice President|14.09.2021 - 31.12.2022||||
||james Sheppard||Secretary|14.09.2021 —31.12.2022||||
||Chris(1an Delles||Treasurer|01.01.2021 —13.09.2022||||
||Luca Facontl||Young Investigator|01.01.2021 —13.09.2022||||
||||Representative|||||
||||Treasurer|13.09.2022 —31.12.2022||||
||Abdul-Majeed|Salmasi|Ordinary<br>Member|01.01.2021 —13.09.2022||||
|7|Stephen<br>Walsh||Ordinary<br>Member|01.01.2021 —13.09.2022||||
||Sinead McDonagh||Young Investigator|13.09.2022 —31.12.2022||||
||||Representative|||||
||Pauline Swift||Ordinary<br>Member|14.09.2021 - 31.12.2022||||
|10|Philip Lewis||Ordinary<br>Member|14.09.2021 - 31.12.2022||||
||Pankaj Gupta||Ordinary<br>Member|13.09.2022 —31.12.2022||||
|12|Sam Olden||Ordinary<br>Member|13.09.2022 —31.12.2022||||
|13||||||||
||Names ofthe|trustees for the charity, ifany, (for example,<br>any custodian|||trustees)|||
||Name|||Dates acted ifnot for whole||ear||





|e<br>e|~ ~<br>~<br>~|
|---|---|
|Description ofthe charity's trusts||
|Type ofgoverning<br>document|Constitution<br>(adopted 21"October 1983,amended<br>24~ September 1984,<br>15th September 2009, 9th September 2013,22"' September 2014,21"|
||September 2015, 22~ September 2016, 25'" September 2018, 13s'|
||Se lember 2022|
|How the charity is constituted|Association|
|Trustee selection methods|Trustees are elected to membership<br>ofthe Executive Committee<br>by BIHS|
||Members at the Annual<br>Business Meeting following a call for nominations|
||earlier in the year|
|Additional<br>governance<br>issues (Optional<br>information)||
|You may choose to include<br>additional<br>information,<br>where<br>relevant,<br>about:|Ordinary<br>and Associate Membership<br>and Fellowship<br>ofthe BIHS is open to all<br>registered<br>healthcare<br>professionals<br>active in the field ofhypertension<br>and<br>cardiovascular<br>disease prevention<br>in the United<br>Kingdom<br>and the Republic of|
||Ireland.<br>Affiliate membership<br>may be granted to healthcare<br>professionals|
|~<br>policies and procedures|residing<br>outside the United<br>Kingdom<br>and Republic of Ireland at the discretion|
|adopted<br>forthe induction<br>and training oftrustees;|ofthe Executive Committee.<br>It includes<br>clinicians,<br>nurses,<br>physiologist s and<br>other scientists.<br>Applications<br>for membership<br>are considered<br>throughout<br>the|
|~<br>the charity's organisational|year.<br>Membership<br>ofthe Society currently<br>stands at 302. Only members<br>and|
|structure<br>and any wider|fellows resident<br>in the United<br>Kingdom<br>and Republic of Ireland are eligible for|
|network<br>with which the|election to the Executive Committee.|
|charity works;||
|~<br>relationship<br>with any related<br>parties;|The management<br>ofthe BIHS is undertaken<br>by an elected Executive<br>Committee of9persons (Trustees),<br>led by the President<br>and Vice President.|
|~<br>trustees'<br>consideration<br>of<br>major risks and the system<br>and procedures<br>to manage<br>them.|Four Standing<br>Committees<br>and two special interests<br>have also been<br>established<br>to help the Executive Committee<br>manage the day-to-day<br>activities<br>ofthe Society (at least one Trustee sits on each ofthe Standing<br>Committees,<br>which are required to submit regular<br>reports to the Executive Committee<br>on its|
||activities).|
||The major risks to the continuation<br>ofthe Society's programme<br>ofeducational|
||activities are from a decrease<br>in income from its industrial<br>partners (see under|
||'Reserves Poli~.<br>Minimal fees to cover administration<br>costs only have been|
||introduced<br>for various projects.|
|Summary<br>ofthe<br>objects ofthe charity<br>The object ofthe Charity is to promote the advancement<br>of knowledge<br>and<br>dissemination<br>of information<br>concerning<br>the pathophysiology,<br>epidemiology,<br>detection,||
|set out in its<br>governing<br>document<br>investigation<br>and treatment<br>ofarterial<br>hypertension<br>and related cardiovascular<br>diseases||
|Summary ofthe<br>~<br>Educational<br>Meetings:<br>Each year, the Society aims to run a main Scientific||
|main activities<br>Meeting. Educational<br>programmes<br>are under review and online options are being||
|undertaken<br>for<br>the public benefit<br>in relation to<br>explored. Various other meetings<br>are held during the year; in collaboration<br>with<br>other cognate societies and/or as ad hoc meetings<br>on specific topics||
|these objects||
|(include within||
|TAR|April 2000|








## 




## 

## 

## 




## 

## 




## 

## 

## 

## 

## 

## 



## 

## 

## 

||||Unrestricted|Unr»strlcted|
|---|---|---|---|---|
||||funds|funds|
||||2022|2021|
|Income from:||Notes|6|6|
|Donations<br>and legacies<br>Charitable<br>activities|||1,421|2,000|
|Conferences<br>and meetings<br>Membership<br>subscriptions<br>Social programmes|||39,570<br>12,921|197,394<br>14,109|
|OMRON licensing agreement<br>Exhibition and sponsorship<br>Derivative device applications<br>Investments|||3,587<br>17,000<br>23,700<br>10,000<br>16,921|3,617<br>17,000<br>13,000<br>11,000<br>16,161|
|Total Income|||125,120|274,281|
|~ECht|||||
|Charitable<br>activities||5|148,818|159,431|
|Net gains/(losses)<br>on Investments||9|(74,110)|70,794|
|Net (expenditure)/income|for the year/||||
|Net movement<br>In funds|||(97,808)|185,644|
|Fund balances at 1 January|2022||788,980|603,336|
|Fund balances at 31 December 2022|||691,172|788,980|





## 

## 

## 

|ASAT31 DECE|MBER|2022|||||||
|---|---|---|---|---|---|---|---|---|
||||||2022||2021||
|||||Notes|6||6|2|
|Fixed assets|||||||||
|Tangible assets|||||||||
|Current assets<br>Debtors<br>Investments<br>Cash at bank and in|hand|||11<br>12|50,633<br>602,730<br>54,221||16,148<br>723,330<br>81,088||
||||||707,584||820,566||
|Creditors: amounts<br>one year|falling|due within||13|(16,412)||(31,586)||
|Net current assets||||||691,172||788,980|
|income funds<br>Unrestricted<br>funds||||||691,172||788,980|
|||||||691,172||788,980|
|Tp<br>t|pp|d pp tp|T d|. .t..).+ct,,',|||||
|Pro<br>ssor TMcCormack|||||||||
|Trustee|||||||||





## 

## 

## 

## 

## 

## 

## 



## 

## 


## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

|||Unrestricted|Unrestricted|
|---|---|---|---|
|||funds|funds|
|||2022f|2021|
|Donations<br>and gifts<br>Stanley Pearl essay fund||421<br>1,000|1,000<br>1,000|
|||1,421|2,000|
|Investments||||
|||Unrestricted|Unrestricted|
|||funds|funds|
|||2022|2021|
|||6||
|Dividends|and interest receivable|16,921|16,161|



## 



## 

## 

## 

|Supportcosts|||||||
|---|---|---|---|---|---|---|
||Support<br>costs<br>2|Governance<br>costs<br>f|2022|Support<br>costs<br>2|Governance<br>costs<br>2|2021|
|Exchange (gains)/losses<br>Admin costs<br>Finance costs|(2,309)<br>61,689<br>1,182||(2,309)<br>61,689<br>1,182|6,347<br>45,942<br>962||6,347<br>45,942<br>962|
||60,562||60,562|53,251||53,251|
|Analysed<br>between|||||||
|Charitable<br>activities|60,562||60,562|53,251||53,251|



## 

## 

|2022|2021|
|---|---|
|Number|Number|



## 

||||||2022|2021|
|---|---|---|---|---|---|---|
|Unreallsed|gain/(loss)|on|COIF|account|(74,110)|70,794|



## 



## 

## 

## 

|Dbt|||||
|---|---|---|---|---|
|eors|||2022|2021|
|Amounts<br>falling due|within one year:||6|6|
|Trade debtors<br>Other debtors<br>Prepaymsnts<br>and accrued income|||4,358<br>38,138<br>8,137|3,258<br>11,828<br>1,062|
||||50,633|16,148|
|Current asset investments|||2022|2021|
|||||6|
|Unlisted<br>investments|||602,730|723,330|
|Creditors: amounts|falling due within one year||2022|2021|
|||Notes|8|6|
|Deferred income<br>Trade creditors<br>Accruals and deferred|income|14|5,000<br>7,077<br>4,335|20,586<br>2,000|
||||16,412|31,586|



|||||||2022|2021|
|---|---|---|---|---|---|---|---|
|||||||6||
|Arising|from|Stanley|Pearl|essay|fund|5,000||



|Deferred|income is|included|in the financial statements<br>as follows|:||
|---|---|---|---|---|---|
|||||2022|2021|
|||||6|8|
|Deferred <br>Current|income is <br>liabifntes|induded|within:|5,000||
|Movements<br>in the year:||||||
|Deferred income at <br>Resources deferred||1 January 2022<br>in the year||5,000||
|Deferred|income at|31 December 2022||5,000||





## 

## 



## 

## 

||Trustee name||Office (ifany)|Dates acted ifnot for whole<br>year|Name ofpemon (or body)<br>entitled ioappoint<br>trustee<br>ifan|Name ofpemon (or body)<br>entitled ioappoint<br>trustee<br>ifan|Name ofpemon (or body)<br>entitled ioappoint<br>trustee<br>ifan|
|---|---|---|---|---|---|---|---|
||Terence McCormack||President|14.09.2021 —31.12.2022||||
||Ian Wilkinson||Vice President|14.09.2021 - 31.12.2022||||
||james Sheppard||Secretary|14.09.2021 —31.12.2022||||
||Chris(1an Delles||Treasurer|01.01.2021 —13.09.2022||||
||Luca Facontl||Young Investigator|01.01.2021 —13.09.2022||||
||||Representative|||||
||||Treasurer|13.09.2022 —31.12.2022||||
||Abdul-Majeed|Salmasi|Ordinary<br>Member|01.01.2021 —13.09.2022||||
|7|Stephen<br>Walsh||Ordinary<br>Member|01.01.2021 —13.09.2022||||
||Sinead McDonagh||Young Investigator|13.09.2022 —31.12.2022||||
||||Representative|||||
||Pauline Swift||Ordinary<br>Member|14.09.2021 - 31.12.2022||||
|10|Philip Lewis||Ordinary<br>Member|14.09.2021 - 31.12.2022||||
||Pankaj Gupta||Ordinary<br>Member|13.09.2022 —31.12.2022||||
|12|Sam Olden||Ordinary<br>Member|13.09.2022 —31.12.2022||||
|13||||||||
||Names ofthe|trustees for the charity, ifany, (for example,<br>any custodian|||trustees)|||
||Name|||Dates acted ifnot for whole||ear||





|e<br>e|~ ~<br>~<br>~|
|---|---|
|Description ofthe charity's trusts||
|Type ofgoverning<br>document|Constitution<br>(adopted 21"October 1983,amended<br>24~ September 1984,<br>15th September 2009, 9th September 2013,22"' September 2014,21"|
||September 2015, 22~ September 2016, 25'" September 2018, 13s'|
||Se lember 2022|
|How the charity is constituted|Association|
|Trustee selection methods|Trustees are elected to membership<br>ofthe Executive Committee<br>by BIHS|
||Members at the Annual<br>Business Meeting following a call for nominations|
||earlier in the year|
|Additional<br>governance<br>issues (Optional<br>information)||
|You may choose to include<br>additional<br>information,<br>where<br>relevant,<br>about:|Ordinary<br>and Associate Membership<br>and Fellowship<br>ofthe BIHS is open to all<br>registered<br>healthcare<br>professionals<br>active in the field ofhypertension<br>and<br>cardiovascular<br>disease prevention<br>in the United<br>Kingdom<br>and the Republic of|
||Ireland.<br>Affiliate membership<br>may be granted to healthcare<br>professionals|
|~<br>policies and procedures|residing<br>outside the United<br>Kingdom<br>and Republic of Ireland at the discretion|
|adopted<br>forthe induction<br>and training oftrustees;|ofthe Executive Committee.<br>It includes<br>clinicians,<br>nurses,<br>physiologist s and<br>other scientists.<br>Applications<br>for membership<br>are considered<br>throughout<br>the|
|~<br>the charity's organisational|year.<br>Membership<br>ofthe Society currently<br>stands at 302. Only members<br>and|
|structure<br>and any wider|fellows resident<br>in the United<br>Kingdom<br>and Republic of Ireland are eligible for|
|network<br>with which the|election to the Executive Committee.|
|charity works;||
|~<br>relationship<br>with any related<br>parties;|The management<br>ofthe BIHS is undertaken<br>by an elected Executive<br>Committee of9persons (Trustees),<br>led by the President<br>and Vice President.|
|~<br>trustees'<br>consideration<br>of<br>major risks and the system<br>and procedures<br>to manage<br>them.|Four Standing<br>Committees<br>and two special interests<br>have also been<br>established<br>to help the Executive Committee<br>manage the day-to-day<br>activities<br>ofthe Society (at least one Trustee sits on each ofthe Standing<br>Committees,<br>which are required to submit regular<br>reports to the Executive Committee<br>on its|
||activities).|
||The major risks to the continuation<br>ofthe Society's programme<br>ofeducational|
||activities are from a decrease<br>in income from its industrial<br>partners (see under|
||'Reserves Poli~.<br>Minimal fees to cover administration<br>costs only have been|
||introduced<br>for various projects.|
|Summary<br>ofthe<br>objects ofthe charity<br>The object ofthe Charity is to promote the advancement<br>of knowledge<br>and<br>dissemination<br>of information<br>concerning<br>the pathophysiology,<br>epidemiology,<br>detection,||
|set out in its<br>governing<br>document<br>investigation<br>and treatment<br>ofarterial<br>hypertension<br>and related cardiovascular<br>diseases||
|Summary ofthe<br>~<br>Educational<br>Meetings:<br>Each year, the Society aims to run a main Scientific||
|main activities<br>Meeting. Educational<br>programmes<br>are under review and online options are being||
|undertaken<br>for<br>the public benefit<br>in relation to<br>explored. Various other meetings<br>are held during the year; in collaboration<br>with<br>other cognate societies and/or as ad hoc meetings<br>on specific topics||
|these objects||
|(include within||
|TAR|April 2000|








## 




## 

## 

## 


